Adverse effects of immune-checkpoint inhibitors in hepatocellular carcinoma
T Cui, Y Liu, J Wang, L Liu - OncoTargets and therapy, 2020 - Taylor & Francis
Immune-modulatory therapy, especially with immune-checkpoint inhibitors (ICIs), has
reshaped cancer therapeutics. Immunotherapy is relatively a novel approach that can …
reshaped cancer therapeutics. Immunotherapy is relatively a novel approach that can …
[引用][C] Adverse Effects of Immune-Checkpoint Inhibitors in Hepatocellular Carcinoma
T Cui, Y Liu, J Wang, L Liu - OncoTargets and Therapy, 2020 - cir.nii.ac.jp
<p>Adverse Effects of Immune-Checkpoint Inhibitors in Hepatocellular Carcinoma</p> | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Adverse Effects of Immune-Checkpoint Inhibitors in Hepatocellular Carcinoma
T Cui, Y Liu, J Wang, L Liu - OncoTargets and Therapy, 2020 - dovepress.com
Immune-modulatory therapy, especially with immune-checkpoint inhibitors (ICIs), has
reshaped cancer therapeutics. Immunotherapy is relatively a novel approach that can …
reshaped cancer therapeutics. Immunotherapy is relatively a novel approach that can …
[HTML][HTML] Adverse Effects of Immune-Checkpoint Inhibitors in Hepatocellular Carcinoma
T Cui, Y Liu, J Wang, L Liu - OncoTargets and therapy, 2020 - ncbi.nlm.nih.gov
Immune-modulatory therapy, especially with immune-checkpoint inhibitors (ICIs), has
reshaped cancer therapeutics. Immunotherapy is relatively a novel approach that can …
reshaped cancer therapeutics. Immunotherapy is relatively a novel approach that can …
Adverse Effects of Immune-Checkpoint Inhibitors in Hepatocellular Carcinoma.
TM Cui, Y Liu, JB Wang, LX Liu - Oncotargets and Therapy, 2020 - europepmc.org
Immune-modulatory therapy, especially with immune-checkpoint inhibitors (ICIs), has
reshaped cancer therapeutics. Immunotherapy is relatively a novel approach that can …
reshaped cancer therapeutics. Immunotherapy is relatively a novel approach that can …
Adverse Effects of Immune-Checkpoint Inhibitors in Hepatocellular Carcinoma
C Tian-ming, Y Liu, J Wang… - OncoTargets and …, 2020 - search.proquest.com
Immune-modulatory therapy, especially with immune-checkpoint inhibitors (ICIs), has
reshaped cancer therapeutics. Immunotherapy is relatively a novel approach that can …
reshaped cancer therapeutics. Immunotherapy is relatively a novel approach that can …
Adverse Effects of Immune-Checkpoint Inhibitors in Hepatocellular Carcinoma.
T Cui, Y Liu, J Wang, L Liu - OncoTargets & Therapy, 2020 - search.ebscohost.com
Immune-modulatory therapy, especially with immune-checkpoint inhibitors (ICIs), has
reshaped cancer therapeutics. Immunotherapy is relatively a novel approach that can …
reshaped cancer therapeutics. Immunotherapy is relatively a novel approach that can …
Adverse Effects of Immune-Checkpoint Inhibitors in Hepatocellular Carcinoma
TM Cui, Y Liu, JB Wang, LX Liu - OncoTargets and …, 2020 - pubmed.ncbi.nlm.nih.gov
Immune-modulatory therapy, especially with immune-checkpoint inhibitors (ICIs), has
reshaped cancer therapeutics. Immunotherapy is relatively a novel approach that can …
reshaped cancer therapeutics. Immunotherapy is relatively a novel approach that can …